The treatment of skin immune diseases represents one of the most successful cases of translational immunology. However, many questions remain regarding the pharmacological mechanisms of biologics, their rational and safe application, long-term patient management, and early intervention. To advance the fields of skin immune diseases, psoriasis, and urticaria, improve precision diagnosis and treatment, promote the rational and safe use of biologics, implement comprehensive chronic disease management, and reduce the disease burden on patients, the "Psoriasis Whole-Life Cycle Management Seminar," organized by the Chengdu High-Tech Medical Association, was successfully held online on March 27, 2025.

        This conference brought together experts and clinicians in the field of rheumatology. By sharing the latest diagnostic and treatment guidelines, cutting-edge research findings, and experiences from typical cases, the event aimed to standardize and improve the diagnosis and treatment of rheumatic diseases. Focusing on multidisciplinary collaboration and personalized treatment strategies, the seminar helped physicians enhance their ability to manage complex cases, fostered the integration of clinical practice and scientific innovation, and ultimately optimized patient management while elevating overall diagnostic and treatment standards.